Ladenburg Thalmann Lowers PT On United Therapeutics To $61

August 25, 2011 8:38 AM | 8 seconds read | Make a Comment

Ladenburg Thalmann has lowered the price target on United Therapeutics

UTHR

from $85 to $61 and maintains its Buy rating.

Posted In: Price Target Analyst Ratings Biotechnology Health Care Ladenburg Thalmann

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.